[go: up one dir, main page]

EA200300835A1 - Новые производные алкилфенилиминоимидазолидина для лечения недержания мочи - Google Patents

Новые производные алкилфенилиминоимидазолидина для лечения недержания мочи

Info

Publication number
EA200300835A1
EA200300835A1 EA200300835A EA200300835A EA200300835A1 EA 200300835 A1 EA200300835 A1 EA 200300835A1 EA 200300835 A EA200300835 A EA 200300835A EA 200300835 A EA200300835 A EA 200300835A EA 200300835 A1 EA200300835 A1 EA 200300835A1
Authority
EA
Eurasian Patent Office
Prior art keywords
derivatives
treatment
new
alkylphenyliminomoimidazozididine
urine holding
Prior art date
Application number
EA200300835A
Other languages
English (en)
Russian (ru)
Inventor
Франц Эссер
Паскаль Пузе
Хисато Китагава
Кенджи Сакаи
Икунобу Мураматсу
Маттиас Хоффманн
Original Assignee
Берингер Ингельхайм Фарма Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берингер Ингельхайм Фарма Гмбх Унд Ко. Кг filed Critical Берингер Ингельхайм Фарма Гмбх Унд Ко. Кг
Publication of EA200300835A1 publication Critical patent/EA200300835A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EA200300835A 2001-02-10 2002-01-22 Новые производные алкилфенилиминоимидазолидина для лечения недержания мочи EA200300835A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10106214A DE10106214A1 (de) 2001-02-10 2001-02-10 Neue Alkyl-phenylimino-imidazolidin-Derivate zur Behandlung der Harninkontinenz
PCT/EP2002/000576 WO2002064570A1 (de) 2001-02-10 2002-01-22 Neue alkyl-phenylimino-imidazolidin-derivate zur behandlung der harninkontinenz

Publications (1)

Publication Number Publication Date
EA200300835A1 true EA200300835A1 (ru) 2004-02-26

Family

ID=7673601

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300835A EA200300835A1 (ru) 2001-02-10 2002-01-22 Новые производные алкилфенилиминоимидазолидина для лечения недержания мочи

Country Status (21)

Country Link
EP (1) EP1362038A1 (et)
JP (1) JP2004517963A (et)
KR (1) KR20030076653A (et)
CN (1) CN1491216A (et)
AR (1) AR035226A1 (et)
BG (1) BG108036A (et)
BR (1) BR0206949A (et)
CA (1) CA2437809A1 (et)
CZ (1) CZ20032146A3 (et)
DE (1) DE10106214A1 (et)
EA (1) EA200300835A1 (et)
EC (1) ECSP034700A (et)
EE (1) EE200300379A (et)
HU (1) HUP0303004A3 (et)
IL (1) IL157297A0 (et)
MX (1) MXPA03007127A (et)
NO (1) NO20033368L (et)
PL (1) PL362149A1 (et)
SK (1) SK10132003A3 (et)
WO (1) WO2002064570A1 (et)
ZA (1) ZA200305609B (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05011841A (es) * 2003-05-09 2006-01-26 Hoffmann La Roche Metil-indoles y metil-pirrolopiridinas como agonistas adrenergicos de alfa-1.
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3190802A (en) * 1961-10-09 1965-06-22 Boehringer Sohn Ingelheim Shaving composition and method of using same
HU192986B (en) * 1984-05-23 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Process for production of imidasodiline derivatives
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
FR2761061B1 (fr) * 1997-03-20 1999-04-23 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives

Also Published As

Publication number Publication date
AR035226A1 (es) 2004-05-05
CA2437809A1 (en) 2002-08-22
ECSP034700A (es) 2003-08-29
PL362149A1 (en) 2004-10-18
DE10106214A1 (de) 2002-08-14
HUP0303004A2 (hu) 2003-12-29
BG108036A (bg) 2004-12-30
EP1362038A1 (de) 2003-11-19
NO20033368D0 (no) 2003-07-28
MXPA03007127A (es) 2003-11-18
HUP0303004A3 (en) 2004-07-28
BR0206949A (pt) 2004-02-25
NO20033368L (no) 2003-07-28
JP2004517963A (ja) 2004-06-17
ZA200305609B (en) 2004-04-29
EE200300379A (et) 2003-12-15
SK10132003A3 (sk) 2004-02-03
CZ20032146A3 (cs) 2003-12-17
KR20030076653A (ko) 2003-09-26
IL157297A0 (en) 2004-02-19
WO2002064570A1 (de) 2002-08-22
CN1491216A (zh) 2004-04-21

Similar Documents

Publication Publication Date Title
EA200400284A1 (ru) Антинеопластические комбинации
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
EA200300929A1 (ru) Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv
DE69907977D1 (de) Pyrrolobenzodiazepine
ATE302775T1 (de) Carbolinderivate
PA8539901A1 (es) Novedosa sal de succinato de o-desmetil-venlafaxina
SE9900100D0 (sv) New compounds
NO20032181L (no) Anvendelse av CCI-779 som et antineoplastisk middel
ATE346067T1 (de) Carbolinderivate
EA200200876A1 (ru) Алкилированные производные имидазопиридина
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
ITMI20010733A0 (it) Uso di inibitori dell'isoenzina cox-2 per il trattamento dell'incontinenza urinaria
PT1413305E (pt) Derivados aril (ou heteroaril) azolilcabrinol para o tratamento de incontinencia urinaria
DE60112960D1 (de) Kondensierte pyridoindolderivate
DE60008400D1 (de) Triazolopyrimidinderivate
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
EA200300835A1 (ru) Новые производные алкилфенилиминоимидазолидина для лечения недержания мочи
EA200200798A1 (ru) Кальцилитические соединения
EA200400877A1 (ru) 2'-гало-3',5'-диалкоксифен-1'-илимино-2-имидазолидиновые производные и их применение для лечения недержания мочи
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
EA200601128A1 (ru) Пиразолопиримидины
EA200300789A1 (ru) Применение 2-амино-1-(4-гидрокси-3-метансульфонамидофенил)этанола для лечения недержания мочи
UY27157A1 (es) Nuevos derivados de alquil-fenilimino-imidazolidina para el tratamiento de la incontinencia urinaria
ECSP034517A (es) Nuevos derivados de m-amino-fenil-imino-imidazolidina para el tratamiento de la incontinencia de orina